Quantcast

Latest Antidepressant Stories

2014-05-04 08:21:24

GeneSight Psychotropic Expands to Cover 38 FDA-Approved Antidepressant and Antipsychotic Medications MASON, Ohio, May 4, 2014 /PRNewswire/ -- Assurex Health today announced an enhancement of its GeneSight® Psychotropic test, providing clinicians with the most comprehensive genetic-based tool available to help them make individualized antidepressant and antipsychotic medication decisions for patients with depression, anxiety, post-traumatic stress disorder (PTSD), bipolar disorder,...

2014-04-30 23:08:05

Bridges to Recovery announces a luxurious residential treatment program for patients suffering from Bipolar disorder. (PRWEB) April 30, 2014 When Bridges to Recovery admits a new patient with an untreated Bipolar Disorder, they immediately review every factor before developing a full comprehensive treatment plan. Due to the associated suicide rate of 10 to 15 percent from untreated Bipolar Disorder, patients need to begin treatment immediately. In contrast to major depression, nearly all...

2014-04-29 09:47:31

Bottom Line: Children and young adults who start antidepressant therapy at high doses, rather than the "modal" [average or typical] prescribed doses, appear to be at greater risk for suicidal behavior during the first 90 days of treatment. Author: Matthew Miller, M.D., Sc.D., of the Harvard School of Public Health, Boston, and colleagues. Background: A previous meta-analysis by the U.S. Food and Drug Administration (FDA) of antidepressant trials suggested that children who received...

2014-04-22 23:15:22

Federal judge to rule on expert witness testimony over allegations that children suffered birth defects due to mothers’ use of Zoloft, Prozac, Celexa, Luvox, Paxil, Lexapro or Viibryd during pregnancies. National network of lawyers continues offer of no-cost consultations to consumers. San Diego, CA (PRWEB) April 22, 2014 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today that a key ruling is being awaited in litigation* alleging...

2014-04-14 12:34:04

SAN DIEGO, April 14, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management. The initial advertisement, which illustrates the struggles that many people face with hunger and body weight, will air on Lifetime, Oxygen, AMC and numerous other networks. BELVIQ is presented as a targeted approach to...

2014-04-11 23:04:32

Houston Attorney Sean Tracey Delivers Opening Statement at Daubert Hearing Houston, TX (PRWEB) April 11, 2014 A Daubert hearing in the Zoloft MDL No. 2342 began on Monday, April 7, in the United States District Court in the Eastern District of Pennsylvania. The hearing relates to the relationship between the antidepressant Zoloft and birth defects. The first of its kind in history, this hearing will determine how future court cases attempting to link SSRI usage and congenital...

2014-04-11 10:11:22

University of Adelaide researchers have found that women on antidepressant medication are more successful at breastfeeding their babies if they keep taking the medication, compared with women who quit antidepressants because of concerns about their babies' health. These results have been presented this week at the 18th Perinatal Society of Australia and New Zealand (PSANZ) Annual Conference in Perth. Using data from the Danish National Birth Cohort in Denmark, researchers in the...

2014-04-10 08:29:47

BOSTON, April 10, 2014 /PRNewswire/ -- Tal Medical, Inc., a clinical-stage company developing breakthrough treatments for psychiatric diseases, has added two industry veterans to its leadership team. Jan Skvarka has joined as the company's President, CEO and member of the Board of Directors, and Ben Shapiro, MD as a member of the Board of Directors. Jan Skvarka is joining Tal after spending 14 years with Bain and Company, a leading global management consultancy. As one of Bain's...

2014-04-09 20:22:18

SCHOFIELD, Wis., April 9, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc. (OTCBB: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is moving forward with the development of their first cannabinoid-based formulation that targets the mental health market by focusing on anxiety and depression. "We believe that with the technologies we have available, PuraMed can utilize hemp-derived compounds to...

2014-04-08 13:06:17

Adult patients with diabetes who trust their medical provider and feel included in treatment decisions are significantly more likely to take and maintain a newly prescribed antidepressant medication, according to a new study in the Journal of General Internal Medicine. The study, conducted by researchers at the Kaiser Permanente Division of Research and the University of Washington, School of Medicine, included 1,500 patients with long-standing diabetes, who were prescribed...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related